Prenatal Multis
Natural health product licensed in Canada
- Other names
- Complete Prenatal Multis, Prenatal Multivitamin & Minerals
- Licence holder
- Bowen Biological Pharmaceuticals (Canada) Inc. Ltd.
- NPN or DIN-HM
- 80103037
- Status
- Inactive licence
- Licence date
- 24 July 2020
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Manganèse: up to 5 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 15 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 15 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Calcium carbonate | 250 mg | 250,000 µg |
| Vitamine B12 Source : Cyanocobalamine | 20 mcg | 20 µg |
| Chrome Source : Chlorure de chrome (III) | 25 mcg | 25 µg |
| Bêta-carotène Source : bêta-carotène | 450 mcg | Not calculated |
| Manganèse Source : Manganèse | 5 mg | 5,000 µg |
| Biotine Source : Biotine | 30 mcg | 30 µg |
| Thiamine Source : Chlorhydrate de thiamine | 10 mg | 10,000 µg |
| Vitamine A Source : Palmitate de vitamine A | 450 mcg EAR | Not calculated |
| Vitamine B6 | 15 mg | 15,000 µg |
| Acide L-ascorbique Source : Ascorbate de calcium | 120 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 25 mcg | 25 µg |
| Vitamine E Source : d-alpha tocophérol | 67 mg AT | Not calculated |
| Riboflavine Source : Riboflavine 5'-phosphate | 10 mg | 10,000 µg |
Non-medicinal ingredients
Croscarmellose de sodium, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
A factor in the maintenance of good health. A factor in the maintenance of good health and normal growth and development. As part of a healthy diet (when taken with Vitamin D) may help prevent bone loss/osteoporosis. Helps pregnant women meet (the) (Health Canada's) recommended intake for iron, when taken in conjunction with a healthy diet. Helps to reduce the risk of neural tube defects when taken daily at least three months prior to becoming pregnant and during early pregnancy. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Stop use if hypersensitivity occurs. Zinc supplementation can cause a copper deficiency. If you are unsure whether you are taking enough copper, consult a health care practitioner prior to use.
- Précautions et mises en garde
Keep out of reach of children. There is enough drug in this package to seriously harm a child.
Source
Official Health Canada record, licence 80103037
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.